Patients generally present with syndromic autosomal OA, with epilepsy, chorea and encephalopathy commonly reported, and it is suggested that more severe symptoms are associated with more deleterious mutations in the RTN4IP1/OPA10 gene (D’Gama et al., 2021). This evidence concerns the gene RTN4IP1 and epilepsy.